GH

Guardant Health
NASDAQ
175.65
+7.81
+4.65%
After Hours: 175.00 -0.65 -0.37% 19:58 09/15 EDT
OPEN
168.25
PREV CLOSE
167.84
HIGH
179.30
LOW
167.00
VOLUME
2.85M
TURNOVER
--
52 WEEK HIGH
179.30
52 WEEK LOW
53.40
MARKET CAP
23.57B
P/E (TTM)
-50.1943
1D
5D
1M
3M
1Y
5Y
1D
Piper Sandler Sticks to Their Buy Rating for Guardant Health (GH)
TipRanks · 22h ago
Guardant Health’s Shield Blood Test For Colorectal Cancer Screening To Be Covered In EviCore By Evernorth Clinical Guidelines Effective January 1, 2027, Per ACS Guidelines
Benzinga · 1d ago
Guardant Health’s Shield Blood Test Covered by EviCore by Evernorth for Colorectal Cancer Screening
Barchart · 1d ago
Weekly Report: what happened at GH last week (0907-0911)?
Weekly Report · 2d ago
Guardant Health (GH) Gets Five Star Precision Oncology Recognition
Simply Wall St · 4d ago
Did WCLC Research Push Just Shift Guardant Health (GH) Stock Narrative?
Simply Wall St · 5d ago
Guardant Health Is Maintained at Buy by UBS
Dow Jones · 6d ago
Guardant Health Price Target Raised to $225.00/Share From $175.00 by UBS
Dow Jones · 6d ago
More
About GH
Guardant Health, Inc. is a precision oncology company focused on guarding wellness and giving every person more time free from cancer. It provides critical insights into what drives disease through its advanced blood and tissue tests, real-world data, and artificial intelligence (AI) analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and helping doctors select the treatment for patients with advanced cancer. For patients with advanced-stage cancer, it has developed Guardant360 laboratory developed test (LDT), and Guardant360 CDx test, a comprehensive liquid biopsy test to provide tumor mutation profiling with solid tumors and to be used as a companion diagnostic in connection with non-small cell lung cancer (NSCLC), and breast cancer. It offers other tests, including Guardant360 Tissue test, Guardant Reveal blood test, Guardant360 Response blood test and others.

Webull offers Guardant Health Inc stock information, including NASDAQ: GH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GH stock methods without spending real money on the virtual paper trading platform.